Product Code: MRFR/CR/9336-CR
Microbiome Cosmetic Products Market-Forecast till 2028
Market Overview
The microbiome cosmetic products market is anticipated to witness a notable CAGR of 6.60% to surpass a value of USD 574.69 Million in 2028. The microbiome is characterized as an assortment of microorganisms that live in a specific spot. Microbiome cosmetic products allude to cosmetic products that cultivate a solid skin microbiome. These organisms shield the skin from microbes, control skin invulnerability, nutrient retention, and backing the skin hindrance.
The worldwide microbiome cosmetic products market saw huge development throughout the course of recent years and is projected to enroll a 6.60% CAGR during the review time frame. The significant development drivers are the emphasis on sound maturing, interest in ensured products, and rising interest in normal fixings in the cosmetic business. In any case, premium evaluation of products and issues regarding viability is set to check the market development of microbiome cosmetic products. By and by, the development of the coordinated retail area in emerging countries is supposed to set out rewarding development and open doors for players working in the microbiome cosmetic products market during the conjecture time frame.
Segment Overview
The microbial component divides the global microbiome cosmetic products market into lactobacillus, lactococcus, streptococcus, acetobacter, leuconostoc, bifidobacterium, saccharomyces, bacillus, pediococcus, zygosaccharomyces, aspergillus, micrococcus, and others. The ingredient segment is made up of probiotic, prebiotic, and postbiotic. The postbiotic segment is sub-segmented as ferment extract, and ferment extract filtrate), extract (extract filtrate and filtrate), ferment (ferment lysate, ferment filtrate, ferment lysate filtrate,lysate (lysate filtrate, lysate extract, and spores), and others.
By format, the market is categorized into cream/lotion, serum, cleanser/face wash, spot treatment, masks, skin tonic/toner, face oil, scrubs, sunscreen, supplements, mist/spray, pads/wipes, gels, and others. In terms of claim, the is classified into acne, hydration, smooth/brighten, environmental damage, cellular aging, wound healing, atopic dermatitis, eczema, rosacea, psoriasis, and others. The consumer group segment bifurcates the market into women and men. The women segment accounted for a larger market share of 76.43% in 2020 and is projected to register a CAGR of 6.53% during the forecast period. The age segment is categorized as babies (0-4), children (5-12), gen z (13 - 24), millennials (25-40), gen x (41-56), baby boomers (57-75), and post-war cohort (+75). The distribution channel divides the global microbiome cosmetic products market into online channels, drug stores & pharmacies, specialty stores, supermarkets & hypermarkets, department stores, and others.
Regional Analysis
Europe represented a vast majority of 38.51% of the worldwide microbiome cosmetic products market in 2020, and the pattern is supposed to go on all through the estimated period.
The developing cosmetics and individual consideration industry in Asia-Pacific, with flood popularity for skincare and medical care products combined with rising per capita discretionary cash flow and evolving ways of life, presents further open doors for market development.
Major Players
The key competitors in the global microbiome cosmetic products market include DSM (Netherland), BASF SE (Germany), Sabsinsa Corporation (US), Rolemi HPC (Italy), Puripharm. (China), L'oreal S.A.(France), HeIQ (Switzerland), Silab (France), Amorepacific Group (South Korea), TULA Life Inc. (US), Gallinee Microbiome Skincare (UK), ESSE SKINCARE (South Africa), Yun Perobiotherapy (Belgium), Estee Lauder Companies Inc. (US), Symrise (Germany), Clariant (Switzerland), Lallemand Inc. (Canada),Aurelia Skincare Ltd (UK), LaFlore Probiotic Skincare (US), Neogenlab (US).
TABLE OF CONTENTS
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 21
- 1.1 MARKET ATTRACTIVENESS ANALYSIS 22
- 1.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY MICROBIAL COMPONENT 23
- 1.1.2 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY INGREDIENT 24
- 1.1.3 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY FORMAT 25
- 1.1.4 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CLAIM 26
- 1.1.5 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CONSUMER GROUP 27
- 1.1.6 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY AGE 28
- 1.1.7 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, DISTRIBUTION CHANNEL 29
- 1.1.8 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY REGION 30
2 MARKET INTRODUCTION 31
- 2.1 DEFINITION 31
- 2.2 SCOPE OF THE STUDY 31
- 2.3 RESEARCH OBJECTIVE 31
- 2.4 MARKET STRUCTURE 32
- 2.5 KEY BUYING CRITERIA 33
3 RESEARCH METHODOLOGY 34
- 3.1 RESEARCH PROCESS 34
- 3.2 PRIMARY RESEARCH 35
- 3.3 SECONDARY RESEARCH 36
- 3.4 MARKET SIZE ESTIMATION 37
- 3.5 FORECAST MODEL 38
- 3.6 LIST OF ASSUMPTIONS & LIMITATIONS 39
4 MARKET DYNAMICS 40
- 4.1 INTRODUCTION 40
- 4.2 DRIVERS 41
- 4.2.1 GROWING SHARE OF GERIATRIC POPULATION WITH AN INCREASING FOCUS ON HEALTHY AGING 41
- 4.2.2 RISING DEMAND FOR NATURAL INGREDIENTS IN THE COSMETIC INDUSTRY 41
- 4.2.3 DRIVERS IMPACT ANALYSIS 42
- 4.3 RESTRAINTS 42
- 4.3.1 PREMIUM PRICING OF PRODUCTS 42
- 4.3.2 ISSUES REGARDING EFFICACY 42
- 4.3.3 RESTRAINTS IMPACT ANALYSIS 43
- 4.4 OPPORTUNITIES 43
- 4.4.1 GROWTH OF THE ORGANIZED RETAIL SECTOR IN DEVELOPING NATIONS 43
5 MARKET FACTOR ANALYSIS 45
- 5.1 VALUE CHAIN ANALYSIS 45
- 5.1.1 RAW MATERIAL PROCUREMENT 47
- 5.1.2 PROCESSING 47
- 5.1.3 PACKAGING 47
- 5.1.4 RAW MATERIAL PROCUREMENT 48
- 5.1.5 PROCESSING 49
- 5.1.6 PACKAGING 49
- 5.2 SUPPLY CHAIN ANALYSIS 50
- 5.3 PORTER'S FIVE FORCES MODEL 52
- 5.3.1 THREAT OF NEW ENTRANTS 52
- 5.3.2 BARGAINING POWER OF SUPPLIERS 53
- 5.3.3 BARGAINING POWER OF BUYERS 53
- 5.3.4 THREAT OF SUBSTITUTES 53
- 5.3.5 INTENSITY OF RIVALRY 54
- 5.4 IMPACT OF THE COVID-19 OUTBREAK ON GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET 54
- 5.4.1 OVERVIEW 54
- 5.4.2 IMPACT ON PRODUCTION 54
- 5.4.3 IMPACT ON SUPPLY-CHAIN 55
- 5.4.4 IMPACT ON PRICING 55
- 5.4.5 IMPACT ON CONSUMER BUYING BEHAVIOR 55
- 5.5 REGULATORY LANDSCAPE 56
- 5.6 PRICING OF MICROBIOME COSMETIC PRODUCTS 57
- 5.6.1 NORTH AMERICA 57
- 5.6.2 EUROPE 58
- 5.6.3 ASIA-PACIFIC 59
- 5.6.4 REST OF THE WORLD 60
6 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY MICROBIAL COMPONENT 61
- 6.1 OVERVIEW 61
- 6.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY MICROBIAL COMPONENT, 2019-2028 62
- 6.2 LACTOBACILLUS 63
- 6.3 LACTOCOCCUS 63
- 6.4 STREPTOCOCCUS 63
- 6.5 ACETOBACTER 64
- 6.6 LEUCONOSTOC 64
- 6.7 BIFIDOBACTERIUM 64
- 6.8 SACCHAROMYCES 65
- 6.9 BACILLUS 65
- 6.10 PEDIOCOCCUS 65
- 6.11 ZYGOSACCHAROMYCES 66
- 6.12 ASPERGILLUS 66
- 6.13 MICROCOCCUS 66
- 6.14 OTHERS 67
7 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY MICROBIAL COMPONENT 68
- 7.1 OVERVIEW 68
- 7.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY INGREDIENT, 2019-2028 69
- 7.2 PROBIOTIC 70
- 7.3 PREBIOTIC 70
- 7.4 POSTBIOTIC 71
8 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY FORMAT 72
- 8.1 OVERVIEW 72
- 8.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY FORMAT, 2019-2028 73
- 8.2 CREAM/LOTION 74
- 8.3 SERUM 74
- 8.4 CLEANSER/FACE WASH 74
- 8.5 SPOT TREATMENT 75
- 8.6 MASKS 75
- 8.7 SKIN TONIC/TONER 75
- 8.8 FACE OIL 76
- 8.9 SCRUBS 76
- 8.10 SUNSCREEN 76
- 8.11 SUPPLEMENTS 77
- 8.12 MIST/SPRAY 77
- 8.13 PADS/WIPES 77
- 8.14 GELS 78
- 8.15 OTHERS 78
9 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CLAIM 79
- 9.1 OVERVIEW 79
- 9.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY CLAIM, 2019-2028 80
- 9.2 ACNE 81
- 9.3 HYDRATION 81
- 9.4 SMOOTH/BRIGHTEN 81
- 9.5 ENVIRONMENTAL DAMAGE 82
- 9.6 CELLULAR AGING 82
- 9.7 WOUND HEALING 82
- 9.8 ATOPIC DERMATITIS 83
- 9.9 ECZEMA 83
- 9.10 ROSACEA 83
- 9.11 PSORIASIS 84
- 9.12 OTHERS 84
10 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY CONSUMER GROUP 85
- 10.1 OVERVIEW 85
- 10.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY CONSUMER GROUP,
2019-2028 86
- 10.2 WOMEN 86
- 10.3 MEN 87
11 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY AGE 88
- 11.1 OVERVIEW 88
- 11.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY AGE, 2019-2028 89
- 11.2 BABIES 90
- 11.3 CHILDREN 90
- 11.4 GEN Z 90
- 11.5 MILLENNIALS 91
- 11.6 GEN X 91
- 11.7 BABY BOOMERS 91
- 11.8 POST-WAR COHORT 92
12 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 93
- 12.1 OVERVIEW 93
- 12.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL,
2019-2028 94
- 12.2 ONLINE CHANNELS 95
- 12.3 DRUG STORES & PHARMACIES 95
- 12.4 SPECIALTY STORES 95
- 12.5 SUPERMARKETS & HYPERMARKETS 96
- 12.6 DEPARTMENT STORES 96
- 12.7 OTHERS 96
13 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET, BY REGION 97
- 13.1 OVERVIEW 97
- 13.1.1 GLOBAL MICROBIOME COSMETIC PRODUCTS MARKET ESTIMATES & FORECAST, BY REGION, 2019-2028 98
- 13.2 NORTH AMERICA 99
- 13.2.1 US 104
- 13.2.2 CANADA 107
- 13.2.3 MEXICO 111
- 13.3 EUROPE 115
- 13.3.1 UK 120
- 13.3.2 GERMANY 123
- 13.3.3 FRANCE 127
- 13.3.4 ITALY 130
- 13.3.5 SPAIN 133
- 13.3.6 REST OF EUROPE 137
- 13.4 ASIA-PACIFIC 141
- 13.4.1 CHINA 146
- 13.4.2 INDIA 149
- 13.4.3 JAPAN 152
- 13.4.4 AUSTRALIA & NEW ZEALAND 156
- 13.4.5 REST OF ASIA-PACIFIC 160
- 13.5 REST OF THE WORLD 164
- 13.5.1 SOUTH AMERICA 168
- 13.5.2 MIDDLE EAST 172
- 13.5.3 AFRICA 175
14 COMPETITIVE LANDSCAPE 179
- 14.1 INTRODUCTION 179
- 14.1.1 MARKET STRATEGY ANALYSIS 179
- 14.2 COMPETITIVE BENCHMARKING 180
- 14.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 181
- 14.3.1 PRODUCT DEVELOPMENTS 181
- 14.3.2 ACQUISITIONS 182
- 14.3.3 CONTRACT & AGREEMENT 183
- 14.3.4 JOIN VENTURE 184
- 14.3.5 EXPANSIONS 184
- 14.3.6 PARTNERSHIPS 184
- 14.3.7 DIVESTMENTS 185
- 14.3.8 RESEARCH & DEVELOPMENT 185
15 COMPANY PROFILES OF MANUFACTURERS 186
- 15.1 DSM 186
- 15.1.1 COMPANY OVERVIEW 186
- 15.1.2 FINANCIAL OVERVIEW 187
- 15.1.3 PRODUCTS OFFERED 187
- 15.1.4 KEY DEVELOPMENTS 188
- 15.1.5 SWOT ANALYSIS 189
- 15.1.6 KEY STRATEGIES 189
- 15.2 BASF SE 190
- 15.2.1 COMPANY OVERVIEW 190
- 15.2.2 FINANCIAL OVERVIEW 190
- 15.2.3 PRODUCTS OFFERED 191
- 15.2.4 KEY DEVELOPMENTS 191
- 15.2.5 SWOT ANALYSIS 192
- 15.2.6 KEY STRATEGIES 192
- 15.3 SYMRISE 193
- 15.3.1 COMPANY OVERVIEW 193
- 15.3.2 FINANCIAL OVERVIEW 193
- 15.3.3 PRODUCTS OFFERED 194
- 15.3.4 KEY DEVELOPMENTS 194
- 15.3.5 SWOT ANALYSIS 195
- 15.3.6 KEY STRATEGIES 195
- 15.4 CLARIANT 196
- 15.4.1 COMPANY OVERVIEW 196
- 15.4.2 FINANCIAL OVERVIEW 197
- 15.4.3 PRODUCTS OFFERED 197
- 15.4.4 KEY DEVELOPMENTS 198
- 15.4.5 SWOT ANALYSIS 199
- 15.4.6 KEY STRATEGIES 199
- 15.5 LALLEMAND INC. 200
- 15.5.1 COMPANY OVERVIEW 200
- 15.5.2 FINANCIAL OVERVIEW 200
- 15.5.3 PRODUCTS OFFERED 200
- 15.5.4 KEY DEVELOPMENTS 201
- 15.5.5 SWOT ANALYSIS 202
- 15.5.6 KEY STRATEGIES 202
- 15.6 HEIQ 203
- 15.6.1 COMPANY OVERVIEW 203
- 15.6.2 FINANCIAL OVERVIEW 203
- 15.6.3 PRODUCTS OFFERED 204
- 15.6.4 KEY DEVELOPMENTS 204
- 15.6.5 KEY STRATEGIES 204
- 15.7 SILAB 205
- 15.7.1 COMPANY OVERVIEW 205
- 15.7.2 FINANCIAL OVERVIEW 205
- 15.7.3 PRODUCTS OFFERED 206
- 15.7.4 KEY DEVELOPMENTS 206
- 15.7.5 KEY STRATEGIES 206
- 15.8 SABINSA CORPORATION 207
- 15.8.1 COMPANY OVERVIEW 207
- 15.8.2 FINANCIAL OVERVIEW 207
- 15.8.3 PRODUCTS OFFERED 207
- 15.8.4 KEY DEVELOPMENTS 208
- 15.8.5 KEY STRATEGIES 208
- 15.9 ROELMI HPC 209
- 15.9.1 COMPANY OVERVIEW 209
- 15.9.2 FINANCIAL OVERVIEW 209
- 15.9.3 PRODUCTS OFFERED 209
- 15.9.4 KEY DEVELOPMENTS 209
- 15.9.5 KEY STRATEGIES 209
- 15.10 PURIPHARM 210
- 15.10.1 COMPANY OVERVIEW 210
- 15.10.2 FINANCIAL OVERVIEW 210
- 15.10.3 PRODUCTS OFFERED 210
- 15.10.4 KEY DEVELOPMENTS 210
- 15.10.5 KEY STRATEGIES 210
16 COMPANY PROFILES OF BUYERS 211
- 16.1 L'OREAL SA. 211
- 16.1.1 COMPANY OVERVIEW 211
- 16.1.2 FINANCIAL OVERVIEW 212
- 16.1.3 KEY DEVELOPMENTS 213
- 16.1.4 SWOT ANALYSIS 213
- 16.1.5 KEY STRATEGIES 213
- 16.2 THE ESTEE LAUDER COMPANIES INC. 214
- 16.2.1 COMPANY OVERVIEW 214
- 16.2.2 FINANCIAL OVERVIEW 215
- 16.2.3 PRODUCTS OFFERED 215
- 16.2.4 KEY DEVELOPMENTS 216
- 16.2.5 THE ESTEE LAUDER COMPANIES INC. 216
- 16.2.6 KEY STRATEGIES 217
- 16.3 AMOREPACIFIC CORP 218
- 16.3.1 COMPANY OVERVIEW 218
- 16.3.2 FINANCIAL OVERVIEW 218
- 16.3.3 KEY DEVELOPMENTS 219
- 16.3.4 SWOT ANALYSIS 219
- 16.3.5 KEY STRATEGIES 220
- 16.4 TULA LIFE INC. 221
- 16.4.1 COMPANY OVERVIEW 221
- 16.4.2 FINANCIAL OVERVIEW 221
- 16.4.3 PRODUCTS OFFERED 221
- 16.4.4 KEY DEVELOPMENTS 223
- 16.4.5 KEY STRATEGIES 223
- 16.5 GALLINEE MICROBIOME SKINCARE 224
- 16.5.1 COMPANY OVERVIEW 224
- 16.5.2 FINANCIAL OVERVIEW 224
- 16.5.3 PRODUCTS OFFERED 224
- 16.5.4 KEY DEVELOPMENTS 224
- 16.5.5 KEY STRATEGIES 225
- 16.6 ESSE SKINCARE 226
- 16.6.1 COMPANY OVERVIEW 226
- 16.6.2 FINANCIAL OVERVIEW 226
- 16.6.3 PRODUCTS OFFERED 226
- 16.6.4 KEY DEVELOPMENTS 227
- 16.6.5 KEY STRATEGIES 228
- 16.7 YUN PEROBIOTHERAPY 229
- 16.7.1 COMPANY OVERVIEW 229
- 16.7.2 FINANCIAL OVERVIEW 229
- 16.7.3 PRODUCTS OFFERED 229
- 16.7.4 KEY DEVELOPMENTS 229
- 16.7.5 KEY STRATEGIES 229
- 16.8 AURELIA SKINCARE LTD 230
- 16.8.1 COMPANY OVERVIEW 230
- 16.8.2 FINANCIAL OVERVIEW 230
- 16.8.3 PRODUCTS OFFERED 230
- 16.8.4 KEY DEVELOPMENTS 230
- 16.8.5 KEY STRATEGIES 230
- 16.9 LAFLORE PROBIOTIC SKINCARE 231
- 16.9.1 COMPANY OVERVIEW 231
- 16.9.2 FINANCIAL OVERVIEW 231
- 16.9.3 PRODUCTS OFFERED 231
- 16.9.4 KEY DEVELOPMENTS 231
- 16.9.5 KEY STRATEGIES 231
- 16.10 NEOGENLAB 232
- 16.10.1 COMPANY OVERVIEW 232
- 16.10.2 PRODUCTS OFFERED 232
- 16.10.3 KEY DEVELOPMENTS 232
- 16.10.4 KEY STRATEGIES 232
17 APPENDIX 233
- 17.1 REFERENCES 233
- 17.2 RELATED REPORTS 233